Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-052021)

Filing Details

Accession Number:: 0001181431-13-052021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-02 16:32:24
Reporting Period:: 2013-09-30

Filing Date:: 2013-10-02
Accepted Time:: 2013-10-02 16:32:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1290166	Qvt Associates Gp Llc	1177 Avenue Of The Americas 9Th Floor New York NY 10036		No	No	Yes	No
1543904	Qvt Fund V Lp	1177 Avenue Of The Americas 9Th Floor New York NY 10036		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2013-09-30	254,900	$3.43	14,212,953	No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value	Disposition	2013-09-30	2,250,000	$3.50	11,962,953	No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value	Disposition	2013-09-30	250,000	$3.27	11,712,953	No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
No	4	S	Indirect	Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.